These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 16521036
21. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus. Invernizzi R, Velasco C, Bramante M, Longo A, Samanin R. Neuropharmacology; 1997; 36(4-5):467-73. PubMed ID: 9225271 [Abstract] [Full Text] [Related]
22. Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex. Ohoyama K, Yamamura S, Hamaguchi T, Nakagawa M, Motomura E, Shiroyama T, Tanii H, Okada M. Eur J Pharmacol; 2011 Feb 25; 653(1-3):47-57. PubMed ID: 21147094 [Abstract] [Full Text] [Related]
23. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens. Ichikawa J, Kuroki T, Dai J, Meltzer HY. Eur J Pharmacol; 1998 Jun 19; 351(2):163-71. PubMed ID: 9686999 [Abstract] [Full Text] [Related]
24. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex. Ichikawa J, Dai J, Meltzer HY. Brain Res; 2002 Jun 07; 939(1-2):34-42. PubMed ID: 12020849 [Abstract] [Full Text] [Related]
25. Long-term administration of cariprazine increases locus coeruleus noradrenergic neurons activity and serotonin1A receptor neurotransmission in the hippocampus. El Mansari M, Ebrahimzadeh M, Hamati R, Iro CM, Farkas B, Kiss B, Adham N, Blier P. J Psychopharmacol; 2020 Oct 07; 34(10):1143-1154. PubMed ID: 32684081 [Abstract] [Full Text] [Related]
26. Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism. Ichikawa J, Dai J, Meltzer HY. Brain Res; 2005 Jul 12; 1049(2):182-90. PubMed ID: 15936730 [Abstract] [Full Text] [Related]
27. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux. Prus AJ, Huang M, Li Z, Dai J, Meltzer HY. Brain Res; 2007 Dec 12; 1184():354-64. PubMed ID: 17988654 [Abstract] [Full Text] [Related]
28. Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters--a rat microdialysis and electrophysiology study. Pehrson AL, Cremers T, Bétry C, van der Hart MG, Jørgensen L, Madsen M, Haddjeri N, Ebert B, Sanchez C. Eur Neuropsychopharmacol; 2013 Feb 12; 23(2):133-45. PubMed ID: 22612991 [Abstract] [Full Text] [Related]
29. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors. Gobert A, Millan MJ. Neuropsychopharmacology; 1999 Aug 12; 21(2):268-84. PubMed ID: 10432475 [Abstract] [Full Text] [Related]
30. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Bymaster FP, Zhang W, Carter PA, Shaw J, Chernet E, Phebus L, Wong DT, Perry KW. Psychopharmacology (Berl); 2002 Apr 12; 160(4):353-61. PubMed ID: 11919662 [Abstract] [Full Text] [Related]
31. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Sharp T, Umbers V, Gartside SE. Br J Pharmacol; 1997 Jul 12; 121(5):941-6. PubMed ID: 9222551 [Abstract] [Full Text] [Related]
32. The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus. Weikop P, Kehr J, Scheel-Krüger J. J Psychopharmacol; 2004 Sep 12; 18(3):395-403. PubMed ID: 15358984 [Abstract] [Full Text] [Related]
33. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism. Dawson LA, Nguyen HQ, Geiger A. Neuropharmacology; 1999 Aug 12; 38(8):1153-63. PubMed ID: 10462128 [Abstract] [Full Text] [Related]
34. The mGlu2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex. Swanson CJ, Perry KW, Schoepp DD. J Neurochem; 2004 Jan 12; 88(1):194-202. PubMed ID: 14675163 [Abstract] [Full Text] [Related]
35. Effects of NBI-98782, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor, on neurotransmitter efflux and phencyclidine-induced locomotor activity: Relevance to tardive dyskinesia and antipsychotic action. Huang M, He W, Rajagopal L, Kudwa A, Grigoriadis DE, Meltzer HY. Pharmacol Biochem Behav; 2020 Mar 12; 190():172872. PubMed ID: 32084491 [Abstract] [Full Text] [Related]
40. Effect of different challenge doses after repeated citalopram treatment on extracellular serotonin level in the medial prefrontal cortex: in vivo microdialysis study. Muraki I, Inoue T, Hashimoto S, Izumi T, Koyama T. Psychiatry Clin Neurosci; 2008 Oct 12; 62(5):568-74. PubMed ID: 18950377 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]